ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies.

M. D. Green^*, P. Alderton, M. M. Sobol, J. Gross, F. M. Muggia, J. L. Speyer

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	101-117
Number of pages	17
Journal	Cancer Treatment and Research
Volume	58
State	Published - 1991
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{fb56ddb3acd74056b77425614ab30bf1,

title = "ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies.",

author = "Green, {M. D.} and P. Alderton and Sobol, {M. M.} and J. Gross and Muggia, {F. M.} and Speyer, {J. L.}",

year = "1991",

language = "אנגלית",

volume = "58",

pages = "101--117",

journal = "Cancer Treatment and Research",

issn = "0927-3042",

publisher = "Springer Netherlands",

}

TY - JOUR

T1 - ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity

T2 - clinical and preclinical studies.

AU - Green, M. D.

AU - Alderton, P.

AU - Sobol, M. M.

AU - Gross, J.

AU - Muggia, F. M.

AU - Speyer, J. L.

PY - 1991

Y1 - 1991

UR - http://www.scopus.com/inward/record.url?scp=0026275276&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 1683780

AN - SCOPUS:0026275276

SN - 0927-3042

VL - 58

SP - 101

EP - 117

JO - Cancer Treatment and Research

JF - Cancer Treatment and Research

ER -